{"entity":{"type":"insider","cik":"0001591098","url":"/insider/0001591098","json_url":"/insider/0001591098.json","name":"Nash Duane","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":23,"first":"2014-10-09","last":"2025-06-16","span_basis":"filed_date"},"name_variants":[{"name":"Nash Duane","source":"filing","n_filings":23,"first_seen":"2014-10-09","last_seen":"2025-06-16"}],"transactions":[{"id":4171892,"accession":"0001193805-25-000885","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-25-000885","line_url":"/filing/0001193805-25-000885#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"IMMUNIC, INC.","issuer_ticker":"IMUX","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.8347,"price_display":"0.83","price_state":"stated","total_value":16694.0,"total_display":"16,694.00","total_whole":"16,694","shares_owned_after":36032.0,"shares_owned_after_display":"36,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-13","filed_date":"2025-06-16","scope":"insider"},{"id":6843024,"accession":"0001193805-22-000787","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-22-000787","line_url":"/filing/0001193805-22-000787#line-2","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"IMMUNIC, INC.","issuer_ticker":"IMUX","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.03,"price_display":"5.03","price_state":"stated","total_value":50300.0,"total_display":"50,300.00","total_whole":"50,300","shares_owned_after":22032.0,"shares_owned_after_display":"22,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-12","filed_date":"2022-05-13","scope":"insider"},{"id":4360996,"accession":"0001193805-21-001159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-001159","line_url":"/filing/0001193805-21-001159#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"IMMUNIC, INC.","issuer_ticker":"IMUX","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.8,"price_display":"9.80","price_state":"stated","total_value":9800.0,"total_display":"9,800.00","total_whole":"9,800","shares_owned_after":15032.0,"shares_owned_after_display":"15,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-10","filed_date":"2021-08-11","scope":"insider"},{"id":5143480,"accession":"0001193805-21-000654","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-21-000654","line_url":"/filing/0001193805-21-000654#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"IMMUNIC, INC.","issuer_ticker":"IMUX","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":12.75,"price_display":"12.75","price_state":"stated","total_value":51000.0,"total_display":"51,000.00","total_whole":"51,000","shares_owned_after":14032.0,"shares_owned_after_display":"14,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-12","scope":"insider"},{"id":8484377,"accession":"0001193805-19-001904","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-19-001904","line_url":"/filing/0001193805-19-001904#line-3","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"IMMUNIC, INC.","issuer_ticker":"IMUX","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4400.0,"shares_display":"4,400","price_per_share":6.96,"price_display":"6.96","price_state":"stated","total_value":30624.0,"total_display":"30,624.00","total_whole":"30,624","shares_owned_after":10032.0,"shares_owned_after_display":"10,032","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-04","filed_date":"2019-12-04","scope":"insider"},{"id":6550282,"accession":"0001562180-18-001042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-18-001042","line_url":"/filing/0001562180-18-001042#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":14.62,"price_display":"14.62","price_state":"stated","total_value":14620.0,"total_display":"14,620.00","total_whole":"14,620","shares_owned_after":21499.0,"shares_owned_after_display":"21,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-16","scope":"insider"},{"id":5314398,"accession":"0001562180-17-003207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-17-003207","line_url":"/filing/0001562180-17-003207#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1188.0,"shares_display":"1,188","price_per_share":19.64,"price_display":"19.64","price_state":"stated","total_value":23332.32,"total_display":"23,332.32","total_whole":"23,332","shares_owned_after":22499.0,"shares_owned_after_display":"22,499","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":4882176,"accession":"0001562180-17-002433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-17-002433","line_url":"/filing/0001562180-17-002433#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":990.0,"shares_display":"990","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":14127.3,"total_display":"14,127.30","total_whole":"14,127","shares_owned_after":23687.0,"shares_owned_after_display":"23,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-03","filed_date":"2017-07-06","scope":"insider"},{"id":4288918,"accession":"0001280776-17-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001280776-17-000059","line_url":"/filing/0001280776-17-000059#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3900.0,"shares_display":"3,900","price_per_share":3.1236,"price_display":"3.12","price_state":"stated","total_value":12182.04,"total_display":"12,182.04","total_whole":"12,182","shares_owned_after":8224.0,"shares_owned_after_display":"8,224","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-08","filed_date":"2017-06-09","scope":"insider"},{"id":5299422,"accession":"0001562180-17-001430","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-17-001430","line_url":"/filing/0001562180-17-001430#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":991.0,"shares_display":"991","price_per_share":9.2021,"price_display":"9.20","price_state":"stated","total_value":9119.2811,"total_display":"9,119.28","total_whole":"9,119","shares_owned_after":24677.0,"shares_owned_after_display":"24,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-03","filed_date":"2017-04-04","scope":"insider"},{"id":4679992,"accession":"0001562180-17-000081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-17-000081","line_url":"/filing/0001562180-17-000081#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1980.0,"shares_display":"1,980","price_per_share":10.4601,"price_display":"10.46","price_state":"stated","total_value":20710.998,"total_display":"20,711.00","total_whole":"20,711","shares_owned_after":25668.0,"shares_owned_after_display":"25,668","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-01-03","filed_date":"2017-01-03","scope":"insider"},{"id":2688971,"accession":"0001562180-16-003208","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-003208","line_url":"/filing/0001562180-16-003208#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1981.0,"shares_display":"1,981","price_per_share":8.9581,"price_display":"8.96","price_state":"stated","total_value":17745.9961,"total_display":"17,746.00","total_whole":"17,746","shares_owned_after":27648.0,"shares_owned_after_display":"27,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-04","scope":"insider"},{"id":2099267,"accession":"0001562180-16-002781","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-16-002781","line_url":"/filing/0001562180-16-002781#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1980.0,"shares_display":"1,980","price_per_share":7.4841,"price_display":"7.48","price_state":"stated","total_value":14818.518,"total_display":"14,818.52","total_whole":"14,819","shares_owned_after":29629.0,"shares_owned_after_display":"29,629","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-06","filed_date":"2016-07-07","scope":"insider"},{"id":8419290,"accession":"0001209191-15-073800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-073800","line_url":"/filing/0001209191-15-073800#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":996.0,"shares_display":"996","price_per_share":8.6519,"price_display":"8.65","price_state":"stated","total_value":8617.2924,"total_display":"8,617.29","total_whole":"8,617","shares_owned_after":31609.0,"shares_owned_after_display":"31,609","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-02","filed_date":"2015-10-05","scope":"insider"},{"id":8094017,"accession":"0001209191-15-059451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-059451","line_url":"/filing/0001209191-15-059451#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":996.0,"shares_display":"996","price_per_share":9.528,"price_display":"9.53","price_state":"stated","total_value":9489.888,"total_display":"9,489.89","total_whole":"9,490","shares_owned_after":32605.0,"shares_owned_after_display":"32,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-02","filed_date":"2015-07-06","scope":"insider"},{"id":9269646,"accession":"0001209191-15-051426","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-051426","line_url":"/filing/0001209191-15-051426#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":996.0,"shares_display":"996","price_per_share":9.0881,"price_display":"9.09","price_state":"stated","total_value":9051.7476,"total_display":"9,051.75","total_whole":"9,052","shares_owned_after":12016.0,"shares_owned_after_display":"12,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-02","filed_date":"2015-06-09","scope":"insider"},{"id":8598704,"accession":"0001209191-15-032676","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-032676","line_url":"/filing/0001209191-15-032676#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":996.0,"shares_display":"996","price_per_share":9.0881,"price_display":"9.09","price_state":"stated","total_value":9051.7476,"total_display":"9,051.75","total_whole":"9,052","shares_owned_after":12016.0,"shares_owned_after_display":"12,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-02","filed_date":"2015-04-06","scope":"insider"},{"id":9269645,"accession":"0001209191-15-051415","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-051415","line_url":"/filing/0001209191-15-051415#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":995.0,"shares_display":"995","price_per_share":11.4607,"price_display":"11.46","price_state":"stated","total_value":11403.3965,"total_display":"11,403.40","total_whole":"11,403","shares_owned_after":12814.0,"shares_owned_after_display":"12,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-06-09","scope":"insider"},{"id":8079151,"accession":"0001209191-15-000998","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-000998","line_url":"/filing/0001209191-15-000998#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":995.0,"shares_display":"995","price_per_share":11.4607,"price_display":"11.46","price_state":"stated","total_value":11403.3965,"total_display":"11,403.40","total_whole":"11,403","shares_owned_after":12814.0,"shares_owned_after_display":"12,814","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-02","filed_date":"2015-01-05","scope":"insider"},{"id":9269644,"accession":"0001209191-15-051393","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-051393","line_url":"/filing/0001209191-15-051393#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5169.0,"shares_display":"5,169","price_per_share":11.1909,"price_display":"11.19","price_state":"stated","total_value":57845.7621,"total_display":"57,845.76","total_whole":"57,846","shares_owned_after":11829.0,"shares_owned_after_display":"11,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-26","filed_date":"2015-06-09","scope":"insider"},{"id":9269306,"accession":"0001209191-15-000984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-000984","line_url":"/filing/0001209191-15-000984#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5169.0,"shares_display":"5,169","price_per_share":11.1909,"price_display":"11.19","price_state":"stated","total_value":57845.7621,"total_display":"57,845.76","total_whole":"57,846","shares_owned_after":11829.0,"shares_owned_after_display":"11,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-26","filed_date":"2015-01-05","scope":"insider"},{"id":7003689,"accession":"0001209191-14-078157","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-14-078157","line_url":"/filing/0001209191-14-078157#line-3","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5169.0,"shares_display":"5,169","price_per_share":11.1909,"price_display":"11.19","price_state":"stated","total_value":57845.7621,"total_display":"57,845.76","total_whole":"57,846","shares_owned_after":11829.0,"shares_owned_after_display":"11,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-26","filed_date":"2014-12-29","scope":"insider"},{"id":9269643,"accession":"0001209191-15-051393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-051393","line_url":"/filing/0001209191-15-051393#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6764.0,"shares_display":"6,764","price_per_share":11.2639,"price_display":"11.26","price_state":"stated","total_value":76189.0196,"total_display":"76,189.02","total_whole":"76,189","shares_owned_after":16998.0,"shares_owned_after_display":"16,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-24","filed_date":"2015-06-09","scope":"insider"},{"id":9269307,"accession":"0001209191-15-000984","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-000984","line_url":"/filing/0001209191-15-000984#line-1","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6764.0,"shares_display":"6,764","price_per_share":11.2639,"price_display":"11.26","price_state":"stated","total_value":76189.0196,"total_display":"76,189.02","total_whole":"76,189","shares_owned_after":16998.0,"shares_owned_after_display":"16,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-24","filed_date":"2015-01-05","scope":"insider"},{"id":7003687,"accession":"0001209191-14-078157","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-078157","line_url":"/filing/0001209191-14-078157#line-2","is_derivative":false,"issuer_cik":"0001517022","issuer_name":"Akebia Therapeutics, Inc.","issuer_ticker":"AKBA","issuer_name_source":null,"issuer_url":"/issuer/0001517022","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6764.0,"shares_display":"6,764","price_per_share":11.2639,"price_display":"11.26","price_state":"stated","total_value":76189.0196,"total_display":"76,189.02","total_whole":"76,189","shares_owned_after":16998.0,"shares_owned_after_display":"16,998","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-24","filed_date":"2014-12-29","scope":"insider"},{"id":6272071,"accession":"0001209191-14-062759","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-062759","line_url":"/filing/0001209191-14-062759#line-1","is_derivative":false,"issuer_cik":"0001280776","issuer_name":"VITAL THERAPIES INC","issuer_ticker":"VTL","issuer_name_source":null,"issuer_url":"/issuer/0001280776","owner_cik":"0001591098","owner_name":"Nash Duane","owner_display_name":"Nash Duane","owner_url":"/insider/0001591098","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":17.5,"price_display":"17.50","price_state":"stated","total_value":1750.0,"total_display":"1,750.00","total_whole":"1,750","shares_owned_after":9324.0,"shares_owned_after_display":"9,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-08","filed_date":"2014-10-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001280776","name":"IMMUNIC, INC.","url":"/issuer/0001280776","role":"Director, Officer (Executive Chairman)","n_filings":7,"first_seen":"2014-10-09","last_seen":"2025-06-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001517022","name":"Akebia Therapeutics, Inc.","url":"/issuer/0001517022","role":"Director","n_filings":16,"first_seen":"2014-12-29","last_seen":"2018-02-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001591098","retrieved_at":"2026-08-24T13:12:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}